Candida albicans Septicemia in a Premature Infant Successfully Treated with Oral Fluconazole
- 1 January 1992
- journal article
- case report
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 24 (5) , 673-675
- https://doi.org/10.3109/00365549209054656
Abstract
A premature male infant, birth-weight 1460 g, was treated successfully for a Candida albicans septicemia with orally administered fluconazole for 20 days. Dosage was 5 mg/kg/day. No side effects were seen. Fluconazole may present a major progress in treatment of invasive C. albicans infections in neonatology.Keywords
This publication has 8 references indexed in Scilit:
- Fluconazole in the treatment of candidiasis in immunocompromised childrenAntimicrobial Agents and Chemotherapy, 1991
- Pharmacokinetics and Tissue Penetration of Fluconazole in HumansClinical Infectious Diseases, 1990
- Amphotericin B as a single agent in the treatment of systemic candidiasis in neonatesThe Pediatric Infectious Disease Journal, 1990
- Fluconazole therapy in an underweight infantEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- ORAL FLUCONAZOLE FOR TREATMENT OF DISSEMINATED FUNGAL INFECTIONThe Pediatric Infectious Disease Journal, 1989
- Mucocutaneous and Invasive Candidiasis Among Very Low Birth Weight (< 1,500 Grams) Infants in Intensive Care Nurseries: A Prospective StudyPediatrics, 1989
- Risk factors associated with candidemia in the neonatal intensive care unitThe Pediatric Infectious Disease Journal, 1987
- Systemic Candidiasis in Very Low-Birth-Weight Infants (<1,500 Grams)Pediatrics, 1984